PLRX

Pliant Therapeutics, Inc.

15.27 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pliant Therapeutics, Inc. stock is up 21.96% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 May’s closed higher than April. In the last 1 Unusual Options Trades, there were 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
26 Mar 13:30 18 Oct, 2024 15.00 PUT 100 2

About Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc. discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins.

  • Citigroup
    Tue May 7, 13:34
    buy
    confirm
  • RBC Capital
    Tue May 7, 11:12
    buy
    confirm
  • Oppenheimer
    Tue May 7, 08:03
    buy
    confirm
  • Needham
    Tue May 7, 07:51
    buy
    confirm
  • HC Wainwright & Co.
    Tue May 7, 06:18
    buy
    confirm